PortfoliosLab logoPortfoliosLab logo
PPH vs. NLR
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

PPH vs. NLR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in VanEck Vectors Pharmaceutical ETF (PPH) and VanEck Uranium and Nuclear ETF (NLR). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, PPH achieves a -0.76% return, which is significantly lower than NLR's 6.14% return. Over the past 10 years, PPH has underperformed NLR with an annualized return of 7.46%, while NLR has yielded a comparatively higher 13.66% annualized return.


PPH

1D
0.33%
1M
-0.56%
YTD
-0.76%
6M
2.14%
1Y
17.87%
3Y*
12.03%
5Y*
9.22%
10Y*
7.46%

NLR

1D
-4.59%
1M
-8.11%
YTD
6.14%
6M
1.51%
1Y
36.84%
3Y*
35.11%
5Y*
21.94%
10Y*
13.66%
*Multi-year figures are annualized to reflect compound growth (CAGR)

PPH vs. NLR - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
PPH
VanEck Vectors Pharmaceutical ETF
-0.76%22.00%8.05%6.95%2.64%17.79%5.49%19.39%-5.89%15.23%
NLR
VanEck Uranium and Nuclear ETF
6.14%56.50%14.26%36.67%2.29%13.63%3.49%0.20%4.94%8.25%

Correlation

The correlation between PPH and NLR is 0.06, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.06

Correlation (3Y)
Calculated over the trailing 3-year period

0.16

Correlation (5Y)
Calculated over the trailing 5-year period

0.31

Correlation (10Y)
Calculated over the trailing 10-year period

0.34

Correlation (All Time)
Calculated using the full available price history since Aug 16, 2007

0.42

Over the past year, the correlation between PPH and NLR has dropped to 0.06 - well below their long-term average of 0.42, suggesting their price drivers have been diverging.

PPH vs. NLR - Sectors Allocation Comparison


Sectors
PPH
NLR

Healthcare

100.0%

-

Industrials

0.1%
15.1%

Basic Materials

-

-

Communication Services

-

-

Consumer Cyclical

-

-

Consumer Defensive

-

-

Energy

-

46.0%

Financial Services

-

-

Real Estate

-

-

Technology

-

1.5%

Utilities

-

37.4%

Healthcare

PPH
100.0%
NLR

-

Industrials

PPH
0.1%
NLR
15.1%

Basic Materials

PPH

-

NLR

-

Communication Services

PPH

-

NLR

-

Consumer Cyclical

PPH

-

NLR

-

Consumer Defensive

PPH

-

NLR

-

Energy

PPH

-

NLR
46.0%

Financial Services

PPH

-

NLR

-

Real Estate

PPH

-

NLR

-

Technology

PPH

-

NLR
1.5%

Utilities

PPH

-

NLR
37.4%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

PPH vs. NLR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PPH
PPH Risk / Return Rank: 2929
Overall Rank
PPH Sharpe Ratio Rank: 2828
Sharpe Ratio Rank
PPH Sortino Ratio Rank: 3030
Sortino Ratio Rank
PPH Omega Ratio Rank: 2828
Omega Ratio Rank
PPH Calmar Ratio Rank: 3333
Calmar Ratio Rank
PPH Martin Ratio Rank: 2727
Martin Ratio Rank

NLR
NLR Risk / Return Rank: 2525
Overall Rank
NLR Sharpe Ratio Rank: 2424
Sharpe Ratio Rank
NLR Sortino Ratio Rank: 2626
Sortino Ratio Rank
NLR Omega Ratio Rank: 2424
Omega Ratio Rank
NLR Calmar Ratio Rank: 2929
Calmar Ratio Rank
NLR Martin Ratio Rank: 2222
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PPH vs. NLR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for VanEck Vectors Pharmaceutical ETF (PPH) and VanEck Uranium and Nuclear ETF (NLR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


PPHNLRDifference
Sharpe ratioReturn per unit of total volatility

+0.17

Sortino ratioReturn per unit of downside risk

+0.21

Omega ratioGain probability vs. loss probability

1.19

1.17

+0.02

Calmar ratioReturn relative to maximum drawdown

1.67

1.43

+0.23

Martin ratioReturn relative to average drawdown

3.88

2.93

+0.96

PPH vs. NLR - Sharpe Ratio Comparison

The current PPH Sharpe Ratio is 1.04, which is comparable to the NLR Sharpe Ratio of 0.88. The chart below compares the historical Sharpe Ratios of PPH and NLR, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


PPHNLRDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.04

0.88

+0.17

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.61

0.75

-0.14

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.44

0.57

-0.13

Sharpe Ratio (All Time)

Calculated using the full available price history

0.30

0.18

+0.12

Drawdowns

PPH vs. NLR - Drawdown Comparison

The maximum PPH drawdown since its inception was -51.45%, smaller than the maximum NLR drawdown of -65.05%. Use the drawdown chart below to compare losses from any high point for PPH and NLR.


Loading charts...

Drawdown Indicators


PPHNLRDifference

Max Drawdown

Largest peak-to-trough decline

-51.45%

-65.05%

+13.60%

Max Drawdown (1Y)

Largest decline over 1 year

-10.76%

-25.80%

+15.04%

Max Drawdown (3Y)

Largest decline over 3 years

-18.06%

-30.48%

+12.42%

Max Drawdown (5Y)

Largest decline over 5 years

-20.26%

-30.48%

+10.22%

Max Drawdown (10Y)

Largest decline over 10 years

-29.70%

-34.35%

+4.65%

Current Drawdown

Current decline from peak

-8.34%

-19.80%

+11.46%

Average Drawdown

Average peak-to-trough decline

-17.31%

-35.72%

+18.41%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.61%

12.61%

-8.00%

Volatility

PPH vs. NLR - Volatility Comparison

The current volatility for VanEck Vectors Pharmaceutical ETF (PPH) is 4.73%, while VanEck Uranium and Nuclear ETF (NLR) has a volatility of 13.18%. This indicates that PPH experiences smaller price fluctuations and is considered to be less risky than NLR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


PPHNLRDifference

Volatility (1M)

Calculated over the trailing 1-month period

4.73%

13.18%

-8.45%

Volatility (6M)

Calculated over the trailing 6-month period

11.67%

32.83%

-21.16%

Volatility (1Y)

Calculated over the trailing 1-year period

17.26%

42.32%

-25.06%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

15.07%

29.24%

-14.17%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

16.96%

24.02%

-7.06%

PPH vs. NLR - Expense Ratio Comparison

PPH has a 0.36% expense ratio, which is lower than NLR's 0.56% expense ratio.


Dividends

PPH vs. NLR - Dividend Comparison

PPH's dividend yield for the trailing twelve months is around 2.12%, less than NLR's 2.40% yield.


PositionTTM20252024202320222021202020192018201720162015
NLR
VanEck Uranium and Nuclear ETF
2.40%2.55%0.76%4.54%2.02%1.99%2.23%2.21%3.91%4.86%3.62%3.30%
PPH
VanEck Vectors Pharmaceutical ETF
2.12%1.78%1.98%2.09%1.55%1.62%1.66%1.77%1.97%1.92%2.43%1.93%

Frequently Asked Questions


PPH and NLR have a correlation of 0.06, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

NLR has higher volatility (13.18%) compared to PPH (4.73%). In terms of maximum drawdown, PPH dropped -51.45% vs NLR's -65.05%.

On 10-year performance, NLR leads with 13.66% vs 7.46% for PPH. On fees, PPH is cheaper at 0.36% per year. On volatility, PPH has been the lower-risk option at 4.73%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 10-year period, NLR has performed better with a 13.66% return vs 7.46%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

PPH is cheaper with a 0.36% expense ratio, compared with 0.56% for NLR.

NLR has the higher dividend yield at 2.40%, compared with 2.12% for PPH.

PPH is categorized as Health & Biotech Equities, while NLR is Alternative Energy Equities. PPH tracks MVIS US Listed Pharmaceutical 25 Index, while NLR tracks MVIS Global Uranium & Nuclear Energy Index. Their fees differ too: 0.36% for PPH and 0.56% for NLR.

PPH currently has the higher Sharpe Ratio (1.04 vs 0.88), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for PPH and NLR

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer